Arrowhead Pharmaceuticals
Buying intent
38 tracked signals | Top 15 topics are below | Sales is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Arrowhead Pharmaceuticals's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
2d ago
3d ago
2d ago
17d ago
2d ago
11d ago
29d ago
16d ago
12d ago
2d ago
29d ago
22d ago
28d ago
15d ago
27d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Arrowhead Pharmaceuticals
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileAt Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development and revolutionizing how we care for hard-to-treat illnesses. As a company we harness collaboration and innovation to rapidly advance drugs from discovery to the clinic. All applicants: Please be aware of employment scams using Arrowhead’s name and the names of Arrowhead
Top accounts researching Arrowhead Pharmaceuticals
names withheld on the public pageThese are companies whose own people brought up Arrowhead Pharmaceuticals unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
1,366 companies · 4,864 people are researching Drug Discovery
Arrowhead Pharmaceuticals's own team shows 3 signals on this topic. No one outside Arrowhead Pharmaceuticals has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Hiring66,174 cos · 318,882 people
- Artificial Intelligence129,094 cos · 649,540 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Marketing — 1 person; Sales — 1 person; Data / Analytics — 1 person; Leadership — 1 person; Operations — 1 person
What's been said
public posts mentioning Arrowhead PharmaceuticalsUp to 9 public excerpts naming Arrowhead Pharmaceuticals from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
We’re hiring interns to build AI Agents & Agentic Systems for Drug Discovery Acceleration at Translational Genetics and Data Science (𝗧𝗚𝗗𝗦) Arrowhead Pharmaceuticals. This role is for builders who actively use 𝗖𝗹𝗮𝘂𝗱𝗲 𝗖𝗼𝗱𝗲, 𝗢𝗽𝗲𝗻𝗔𝗜 / Gemini APIs, Google Gemma 4, autonomous AI agents, databases, and web scraping to create real 𝗶𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝘀𝘆𝘀𝘁𝗲𝗺𝘀—not demos. Interns will design agentic pipelines for large-scale information collection, siRNA drug target identification and validation, and automated report generation, integrating signals from UK Biobank (𝗨𝗞𝗕), All of Us (𝗔𝗼𝗨), FinnGen, Genomics England, Open Targets, 𝗣𝘂𝗯𝗠𝗲𝗱, 𝗯𝗶𝗼𝗥𝘅𝗶𝘃, patent databases, and 𝗿𝗲𝗮𝗹-𝘁𝗶𝗺𝗲 scientific and industry discourse across Twitter, LinkedIn, and Reddit. We welcome applicants engaged with communities such as ASHG, OTS, and other genetics, genomics, and AI-in-biomedicine forums. If you’re excited about turning noisy, 𝗳𝗿𝗮𝗴𝗺𝗲𝗻𝘁𝗲𝗱 data into production-grade 𝗶𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 that directly informs drug discovery decisions, we strongly encourage you to apply and bring bold ideas to the table. https://lnkd.in/gm2Yz3QF #AIAgents #DrugDiscovery #Bioinformatics #ComputationalBiology #Genomics #MachineLearning #LLM #PrecisionMedicine #BiotechCareers #DataScience Front Line Genomics ISCB - International Society for Computational Biology Oligonucleotide Therapeutics Society (OTS)
Strategic priorities
Earnings call; SEC filingsNegotiation; Patient +; Winning Strategies ITS; Pharmaceutical
What changed recently
Earnings call; SEC filingsNegotiation